BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260302T170000
DTEND;TZID=Australia/Sydney:20260302T170000
DTSTAMP:20260416T012038
CREATED:20260203T032740Z
LAST-MODIFIED:20260203T032740Z
UID:10000245-1772470800-1772470800@melanoma.org.au
SUMMARY:CRI Postdoctoral Fellowships
DESCRIPTION:CRI Irvington and CRI Immuno-Informatics Postdoctoral Fellowship Program  \nThe CRI Irvington Postdoctoral Fellowship Program is one of the most prestigious training opportunities in immunology and cancer immunology. It supports outstanding young researchers at the world’s leading universities and research institutions\, providing the resources\, mentorship\, and professional development needed to launch independent scientific careers at the forefront of discovery. \nThe CRI Immuno-Informatics Postdoctoral Fellowship Program supports outstanding early-career scientists worldwide who seek dual expertise in immunology and data science. This unique program fosters a new generation of researchers fluent in both biology and computation\, equipping them to drive innovation in cancer immunotherapy. \nFellowships provide three years of support\, including a stipend of $74\,000\, $76\,000\, and $78\,000 in years 1-3. The host institution receives a $5\,000 annual allowance for use at the sponsor’s discretion to cover costs such as research supplies\, conference travel\, health insurance\, or childcare. CRI also provides dedicated support for fellows to attend the CRI Bioinformatics Bootcamp. Deductions for administrative overhead are not allowed from either the stipend or the institutional allowance. \nKey Dates \nApplication deadlines: 2 March and 1 September 2026 \nSEE CRI IRVINGTON GUIDELINESSEE CRI IMMUNO-INFORMATICS GUIDELINES
URL:https://melanoma.org.au/event/cri-postdoc-fellowships/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/CRI-PostDoc-Fellow-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260306T235900
DTEND;TZID=Australia/Sydney:20260306T235900
DTSTAMP:20260416T012038
CREATED:20260211T233409Z
LAST-MODIFIED:20260211T233409Z
UID:10000254-1772841540-1772841540@melanoma.org.au
SUMMARY:CPC Catchlove Sylvan Mid-Career Researcher Fellowship
DESCRIPTION:Applications for the Charles Perkins Centre Catchlove Sylvan Mid-Career Researcher Fellowship 2026 are now open. Inaugurated in 2025\, this bridging support scheme is designed to help our best mid-career researchers remain in academia. \nThe Fellowship is made possible with generous support from our long-time friends\, philanthropists\, Dr Barry Catchlove and Professor Louise Sylvan. In its inaugural year\, the scheme supported three of our brightest mid-career researchers. \nIn 2026\, up to three awards\, with a maximum value of $100\,000 each\, will be available for Charles Perkins Centre mid-career researchers. \nKey Dates \nApplications close: Friday 6 March 2026 \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/cpc-catchlove-fellowship/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/Charles_Perkins_Centre-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260309T170000
DTEND;TZID=Australia/Sydney:20260309T170000
DTSTAMP:20260416T012038
CREATED:20260203T032013Z
LAST-MODIFIED:20260203T032013Z
UID:10000246-1773075600-1773075600@melanoma.org.au
SUMMARY:Rising Tide Clinical Cancer Research Program
DESCRIPTION:RTFCCR invites academic institutions and not-for-profit organizations to collaborate on innovative\, patient-centered clinical trials. Our mission is to improve cancer patients’ treatment options and quality of life by funding studies focused on detection\, treatment\, and implementation. \nWe support phase I to phase III interventional clinical trials but do not fund basic research\, phase IV trials\, or observational studies. Funding is available to institutions worldwide where effective grant oversight is feasible. \nSubmission Criteria \n\nThe interventional clinical trial can be an early—to—late—stage clinical trial (Phase 1\, 2\, and 3) with a patient partner involvement in the study protocol design.\nOnly applications aimed at detecting and intervening in early cancer (pre-cancerous changes) can also be considered at the pre-clinical validation stage.\nPharmaceutical agents used in the study can be generic (off-patent repurposing)\, registered for this indication\, or under development by an academic institution.\nClinical trials testing immunotherapies should be discussed with RTFCCR before application submission.\nFinal selection will be contingent on scientific review\, strategic portfolio fit\, and availability of funds\n\nKey Dates \nApplication deadlines: 9 March\, 22 June and 23 November 2026 \nSEE FUNDING GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/rising-tide-research-program/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/RisingTide600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260309T170000
DTEND;TZID=Australia/Sydney:20260309T170000
DTSTAMP:20260416T012038
CREATED:20260210T034150Z
LAST-MODIFIED:20260210T034150Z
UID:10000251-1773075600-1773075600@melanoma.org.au
SUMMARY:Sydney Cancer Partners SERCI Grant
DESCRIPTION:SCP Small Equipment and Research Capacity Building Infrastructure (SERCI) Grant \nThe objective is to support SCP members to complete internationally competitive translational cancer research projects by improving access to specialised research equipment or software. \nApplicants may request funds to purchase equipment\, software or software licenses with a total purchase cost of up to $50K (excluding GST). There is no minimum cost request. Equipment/software purchased under this scheme must be located and/or accessed at a Sydney Health Partners member institution. \nKey Dates \nScheme Open: 9 February 2026  \nScheme Close: 5 pm\, 9 March 2026 \nNotification of outcomes: 10 April 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/scp-serci-grant/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/Sydney_Cancer_Partners-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260311T170000
DTEND;TZID=Australia/Sydney:20260311T170000
DTSTAMP:20260416T012038
CREATED:20260203T030555Z
LAST-MODIFIED:20260203T030555Z
UID:10000242-1773248400-1773248400@melanoma.org.au
SUMMARY:ARC Discovery Early Career Researcher Award
DESCRIPTION:The DECRA scheme provides focused research support for early career researchers in both teaching and research\, and research-only positions. \nIt’s objectives are to: \n\nsupport outstanding early-career researchers with demonstrated capacity for high-quality research and emerging capability for leadership and supervision\nfoster collaboration\, with national or international researchers\nsupport excellent and innovative research that addresses a significant problem or gap in knowledge and represents value for money\ncreate new or advanced knowledge resulting from the outcomes of the research with economic\, commercial\, environmental\, social and/or cultural benefits for Australia\nadvance promising early career researchers and promote enhanced opportunities for diverse career pathways in high-quality and supportive environments.\n\nThe DECRA scheme provides funding for three-year DECRAs\, providing a researcher with salary and on-costs\, and up to $50\,000 per year in project costs. \nProject funding may be used for: \n\npersonnel\, postdoctoral research associates and research assistants\, technicians and laboratory attendants\naccess to research and infrastructure facilities and technical workshop services\nessential field research\nexpert third party services\nequipment and consumables\npublication and dissemination of project research outputs and outreach activities\nspecialised computer equipment and software\ntravel costs essential to the project for up to $50\,000 over the project activity period\nweb hosting and development\nworkshops\, focus groups and conferences\, and\nreasonable essential costs for researchers who are carers or who themselves require care.\n\nKey Dates \nApplications Close: 11 MARCH 2026 \nAnticipated Announcement: 10 December 2026 – 9 March 2027 \nSEE GRANT GUIDELINES PDFSEE GRANT GUIDELINES CHANGES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/arc-discovery-early-career/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/ARC-Discovery-Early-Career-Researcher-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260318T170000
DTEND;TZID=Australia/Sydney:20260318T170000
DTSTAMP:20260416T012038
CREATED:20260203T031044Z
LAST-MODIFIED:20260203T031044Z
UID:10000243-1773853200-1773853200@melanoma.org.au
SUMMARY:ARC Linkage Projects
DESCRIPTION:The Linkage Program promotes national and international research partnerships between researchers and business\, industry\, community organisations and other publicly funded research agencies. By supporting the development of partnerships\, the ARC encourages the transfer of skills\, knowledge and ideas as a basis for securing commercial and other benefits of research. \nThe Linkage Projects grant opportunity supports projects which initiate or develop long term strategic research alliances to apply advanced knowledge to problems\, acquire new knowledge and as a basis for securing commercial and other benefits of research. \nThere will be one assessment round for Linkage Projects 2026. \nThe Linkage Projects scheme objectives are to: \n\nsupport internationally competitive research projects and teams on challenges or opportunities of relevance to research end-users;\nfoster the establishment and strengthening of research alliances between higher education organisations and research end-users;\nenhance the scale and focus of research\, including in Australian Government priority areas.\n\nApplications for funding under the Linkage Projects scheme must include at least one Partner Organisation. The Partner Organisation must make a contribution in cash and/or in kind to the project. The combined Partner Organisation contributions for an application (i.e. the total of the cash and in-kind contributions of the Partner Organisations) must at least match the total funding requested from the ARC. \nThe Linkage Projects scheme provides project funding of $50\,000 to $300\,000 per year for two to five years. \nThis scheme is intended to support researchers from higher education organisations and industry to build partnerships with organisations\, to conduct research which will benefit the organisations and Australia. \nKey Dates \nApplications close: 18 March 2026 \nAnnouncement: 10 December 2026 to 9 March 2027 \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/arc-linkage-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/ARC-Linkage-Projects-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260320T170000
DTEND;TZID=Australia/Sydney:20260320T170000
DTSTAMP:20260416T012038
CREATED:20260106T033820Z
LAST-MODIFIED:20260107T084506Z
UID:10000227-1774026000-1774026000@melanoma.org.au
SUMMARY:Friends of the Mater 2026 Annual Grants
DESCRIPTION:The Friends of the Mater Foundation provides an annual grant funding program to support and enhance high quality patient care\, clinical practice\, research and education across the Mater Hospital campus. Foundation grants are available to medical clinicians\, nurses and allied health professionals at the Mater and will be awarded according to potential benefits to patient care outcomes. The amount of grant funding available each year is determined by the interest earnt on the Foundation’s capital. \nThe Friends of The Mater Foundation allocated grants to advance The Mater Hospital as a Centre of excellence in health services and to achieve the best healthcare outcomes for patients. \nGrants are awarded for equipment\, facilities\, research and clinical education programs. \nApplications are invited from medical clinicians\, nurses and allied health professionals across all departments of the Mater Hospital. \nKey Dates\nApplications close: Friday 20 March 2026\, 5.00pm AEDT \nSEE WEBSITE
URL:https://melanoma.org.au/event/fom-annual-grants-2026/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/12/Friends-Of-Mater-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260326T170000
DTEND;TZID=Australia/Sydney:20260326T170000
DTSTAMP:20260416T012038
CREATED:20260302T235556Z
LAST-MODIFIED:20260303T235853Z
UID:10000263-1774544400-1774544400@melanoma.org.au
SUMMARY:The Ian Potter Foundation Medical Research Program
DESCRIPTION:The Healthy pillar supports organisations that strive to provide innovative solutions to improve the health of all Australians. The Medical Research program aims to advance understanding and improve treatment of major diseases by supporting leading Australian research institutes\, universities and teaching hospitals in innovative biomedical research. \nIn the Medical Research program the Foundation will consider applications: \n\nTo support the provision of equipment and capital infrastructure to support outstanding research groups.\nThe minimum grant amount is $100\,000 (for a single instrument or piece of equipment) in this program area.\n\nKey Dates\nApplications close: Thursday 26 March 2026\, 5 pm AEDT\nGrants Announced: late June 2026 \nSEE GRANT CONDITIONSSEE WEBSITE
URL:https://melanoma.org.au/event/ian-potter-mrp/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Ian_Potter_Foundation600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260331T235900
DTEND;TZID=Australia/Sydney:20260331T235900
DTSTAMP:20260416T012038
CREATED:20260203T024755Z
LAST-MODIFIED:20260203T024755Z
UID:10000249-1775001540-1775001540@melanoma.org.au
SUMMARY:The Viertel Charitable Foundation Fellowship
DESCRIPTION:The Sylvia & Charles Viertel Charitable Foundation invites applications for the Senior Medical Research Fellowships valued at $275\,000 per annum (total $1\,375\,000 over 5 years) to commence in 2027. \nThis funding opportunity is designed to support: \n\nearly to mid-career researchers qualified to at least the post-doctoral level (no more than 10 years post-doc\, taking into account career disruptions);\nwho are outstanding researchers;\nwho do not currently hold a senior research or teaching position;\nwho are medically qualified\, or PhD graduates of another scientific discipline with recognised post-doctoral achievements;\nwho are seeking to establish a research career in Australia and undertake research in an Australian academic institution; and\nwho are either an Australian citizen or permanent resident of Australia\, or a New Zealand citizen with a Special Category (subclass 444) visa.\n\nKey Dates \nApplications close: 31 March 2026 11:59pm (AEST) \nSEE GRANT GUIDELINES PDFAPPLY HERESEE WEBSITE
URL:https://melanoma.org.au/event/viertel-foundation-fellowship/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/The-Viertel-Charitable-Foundation-600-x-338-px-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR